Page last updated: 2024-09-03

13-azaprostanoic acid and arachidonic acid

13-azaprostanoic acid has been researched along with arachidonic acid in 11 studies

Compound Research Comparison

Studies
(13-azaprostanoic acid)
Trials
(13-azaprostanoic acid)
Recent Studies (post-2010)
(13-azaprostanoic acid)
Studies
(arachidonic acid)
Trials
(arachidonic acid)
Recent Studies (post-2010) (arachidonic acid)
420019,2954863,040

Protein Interaction Comparison

ProteinTaxonomy13-azaprostanoic acid (IC50)arachidonic acid (IC50)
60 kDa heat shock protein, mitochondrialHomo sapiens (human)4.5
Fatty acid-binding protein, adipocyteHomo sapiens (human)2.75
10 kDa heat shock protein, mitochondrialHomo sapiens (human)4.5
60 kDa chaperonin Escherichia coli7.3
10 kDa chaperonin Escherichia coli7.3
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)1.0715
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.6026

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-199010 (90.91)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brace, LD; Le Breton, GC; Venton, DL2
Doran, J; Fitzgerald, DJ; FitzGerald, GA; Jackson, E1
Cassina, G; Livio, M; Macconi, D; Morelli, C; Morzenti, G; Remuzzi, G1
Bertelé, V; Castagnoli, MN; Cerletti, C; de Gaetano, G; Rajtar, G1
Ghali, NI; Hung, SC; Kattelman, EJ; Le Breton, GC; Schnorf, KE; Venton, DL1
Le Breton, GC; Parise, LV; Venton, DL1
Feinberg, H; Ho, T; Le Breton, GC; Lipowski, JP; Venton, DL; Wu, KK1
Hall, ER; Papp, A; Wu, KK1
Colwell, JA; Goldberg, AK; Halushka, PV; Loadholt, CB; Mayfield, R; McCoy, SA; Rogers, RC; Wohltmann, HJ1
Casonato, A; Deana, R; Francesconi, M; Girolami, A; Scapin, M1

Reviews

1 review(s) available for 13-azaprostanoic acid and arachidonic acid

ArticleYear
Modulation of vascular thrombosis by products of arachidonic acid metabolism.
    Clinical physiology and biochemistry, 1984, Volume: 2, Issue:2-3

    Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Chromatography, Gel; Epoprostenol; Humans; Imidazoles; In Vitro Techniques; Prostanoic Acids; Serum Albumin; Thrombophlebitis; Thromboxane A2; Thromboxane-A Synthase

1984

Other Studies

10 other study(ies) available for 13-azaprostanoic acid and arachidonic acid

ArticleYear
Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
    The American journal of physiology, 1985, Volume: 249, Issue:1 Pt 2

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcium; Chlortetracycline; Cyclic AMP; Epoprostenol; Humans; Ion Channels; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Stimulation, Chemical; Thromboxane A2; Thromboxanes

1985
Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
    The Journal of clinical investigation, 1986, Volume: 77, Issue:2

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Arterial Occlusive Diseases; Bridged Bicyclo Compounds, Heterocyclic; Coronary Vessels; Dibenzothiepins; Dogs; Fatty Acids, Unsaturated; Hydrazines; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Aggregation; Prostaglandin Endoperoxides; Prostanoic Acids; Rats; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2

1986
Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Laboratory investigation; a journal of technical methods and pathology, 1985, Volume: 52, Issue:2

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Catechols; Chromatography, Thin Layer; Cyclooxygenase Inhibitors; Humans; Imidazoles; In Vitro Techniques; Lipoxygenase Inhibitors; Masoprocol; Phospholipases; Platelet Activating Factor; Platelet Aggregation; Prostanoic Acids; Quinacrine; Radioimmunoassay; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase

1985
Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Biochemical pharmacology, 1985, Feb-01, Volume: 34, Issue:3

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Dinoprost; Dinoprostone; Drug Synergism; Humans; Imidazoles; Oxidoreductases; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins D; Prostaglandins E; Prostaglandins F; Prostanoic Acids; Thromboxane B2; Thromboxane-A Synthase

1985
Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    The American journal of physiology, 1985, Volume: 249, Issue:1 Pt 2

    Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcium; Chlortetracycline; Epoprostenol; Humans; Indomethacin; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Stimulation, Chemical; Thromboxane A2; Thromboxanes

1985
Synthesis of [17,18-3H] trans-13-azaprostanoic acid. A labeled probe for the PGH2/TXA2 receptor.
    Prostaglandins, 1984, Volume: 27, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Arachidonic Acids; Fatty Acids; Humans; In Vitro Techniques; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostanoic Acids; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Structure-Activity Relationship

1984
Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
    The Journal of pharmacology and experimental therapeutics, 1984, Volume: 228, Issue:1

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Drug Interactions; Humans; In Vitro Techniques; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxanes

1984
Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
    The Journal of pharmacology and experimental therapeutics, 1984, Volume: 229, Issue:1

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Fatty Acids; Male; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Rabbits; Thrombosis; Thromboxane A2; Thromboxanes

1984
Increased platelet arachidonic acid metabolism in diabetes mellitus.
    Diabetes, 1981, Volume: 30, Issue:Suppl 2

    Topics: Arachidonic Acid; Arachidonic Acids; Blood Glucose; Blood Platelets; Diabetes Mellitus; Epinephrine; Humans; Kinetics; Platelet Aggregation; Prostanoic Acids; Thromboxane B2

1981
Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes.
    Thrombosis research, 2000, Nov-15, Volume: 100, Issue:4

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Antagonists; Arachidonic Acid; Aspirin; Blood Platelets; Calcium; Drug Synergism; Epinephrine; Humans; Kinetics; Lipoxygenase; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Prostanoic Acids; Serotonin; Sympathomimetics; Thromboxanes; Tyrosine; Vasoconstrictor Agents; von Willebrand Factor; Yohimbine

2000